These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34722326)

  • 1. New Insights Into Blue Light Phototherapy in Experimental
    Ivanova N; Leite ALJ; Vieira MB; Silva OHCE; Mota LWR; Costa GP; de Azevedo CS; Auharek SA; Novaes RD; Pinto KMC; Bianchi RF; Talvani A
    Front Cell Infect Microbiol; 2021; 11():673070. PubMed ID: 34722326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.
    Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J
    J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection.
    Paiva CN; Figueiredo RT; Kroll-Palhares K; Silva AA; Silvério JC; Gibaldi D; Pyrrho Ados S; Benjamim CF; Lannes-Vieira J; Bozza MT
    J Leukoc Biol; 2009 Nov; 86(5):1239-46. PubMed ID: 19641038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Chagas disease, transforming growth factor beta neutralization reduces
    Ferreira RR; de Souza EM; Vilar-Pereira G; Degrave WMS; Abreu RDS; Meuser-Batista M; Ferreira NVC; Ledbeter S; Barker RH; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
    Front Cell Infect Microbiol; 2022; 12():1017040. PubMed ID: 36530434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
    Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
    Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
    Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
    Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with
    Horta AL; Leite AL; Paula Costa G; Figueiredo VP; Talvani A
    Biomed Res Int; 2017; 2017():9205062. PubMed ID: 28377930
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.
    Sanoja C; Carbajosa S; Fresno M; Gironès N
    PLoS One; 2013; 8(6):e65820. PubMed ID: 23776551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.
    Jones KM; Mangin EN; Reynolds CL; Villanueva LE; Cruz JV; Versteeg L; Keegan B; Kendricks A; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ
    Front Cell Infect Microbiol; 2023; 13():1106315. PubMed ID: 36844399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into IL-33 on inflammatory response during in vitro infection by Trypanosoma cruzi.
    Oliveira DS; Leite ALJ; Pedrosa TCF; Mota LWR; Costa GP; Souza DMS; Perucci LO; Talvani A
    Immunobiology; 2022 Jul; 227(4):152243. PubMed ID: 35839730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection.
    Shrestha D; Bajracharya B; Paula-Costa G; Salles BC; Leite AL; Menezes AP; Souza DM; Oliveira LA; Talvani A
    Microvasc Res; 2017 Mar; 110():56-63. PubMed ID: 27956355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
    Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-9 in Immunopathology of
    Silva NSL; Orikaza CM; de Santana FR; Dos Santos LA; Salu BR; Oliva MLV; Sinigaglia RC; Mortara RA
    Front Cell Infect Microbiol; 2021; 11():756521. PubMed ID: 34722343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection.
    Caldas S; Caldas IS; Diniz Lde F; Lima WG; Oliveira Rde P; Cecílio AB; Ribeiro I; Talvani A; Bahia MT
    Acta Trop; 2012 Sep; 123(3):170-7. PubMed ID: 22609548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.
    de Paula Costa G; Silva RR; Pedrosa MC; Pinho V; de Lima WG; Teixeira MM; Bahia MT; Talvani A
    Parasite Immunol; 2010 Mar; 32(3):202-8. PubMed ID: 20398183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
    Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
    PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.